(LEN) Lennar - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US5260571048
Stock: Single-Family Homes, Multifamily Rentals, Mortgage Financing, Land Development
Total Rating 43
Risk 88
Buy Signal -0.76
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.76% |
| Yield on Cost 5y | 2.56% |
| Yield CAGR 5y | 90.27% |
| Payout Consistency | 84.8% |
| Payout Ratio | 24.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 34.1% |
| Relative Tail Risk | -3.08% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.18 |
| Alpha | -20.53 |
| Character TTM | |
|---|---|
| Beta | 0.647 |
| Beta Downside | 0.455 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.27% |
| CAGR/Max DD | 0.25 |
Description: LEN Lennar December 17, 2025
Lennar Corporation (NYSE:LEN) is the largest U.S. homebuilder, operating under the Lennar brand across five regional homebuilding segments (East, Central, Texas, West, and Other) as well as Financial Services, Multifamily, and ancillary businesses. Its core activities include constructing and selling single-family attached and detached homes, developing residential land, and managing multifamily rental properties, while also providing mortgage financing, title, insurance, and closing services, and originating commercial mortgage-backed securities.
Key recent metrics illustrate the scale and market exposure of the business: FY 2023 revenue reached approximately $27.6 billion with a net income of $2.4 billion, and the company reported a home-sales backlog of roughly $30 billion, equivalent to about 12 months of pipeline at current build rates. Average selling prices have risen to roughly $400 k, driven by limited inventory and higher construction costs, while the U.S. housing-starts index and mortgage-rate volatility remain primary macro drivers of demand and profitability.
For a deeper dive into LEN’s valuation metrics and scenario analysis, you might explore the ValueRay platform.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 2.08b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -5.32 > 1.0 |
| NWC/Revenue: 34.12% < 20% (prev 53.90%; Δ -19.78% < -1%) |
| CFO/TA 0.01 > 3% & CFO 216.8m > Net Income 2.08b |
| Net Debt (2.51b) to EBITDA (2.95b): 0.85 < 3 |
| Current Ratio: 3.12 > 1.5 & < 3 |
| Outstanding Shares: last quarter (252.4m) vs 12m ago -5.57% < -2% |
| Gross Margin: 17.62% > 18% (prev 0.23%; Δ 1739 % > 0.5%) |
| Asset Turnover: 90.13% > 50% (prev 85.87%; Δ 4.26% > 0%) |
| Interest Coverage Ratio: 23.82 > 6 (EBITDA TTM 2.95b / Interest Expense TTM 118.1m) |
Altman Z'' 6.77
| A: 0.34 (Total Current Assets 17.14b - Total Current Liabilities 5.50b) / Total Assets 34.43b |
| B: 0.65 (Retained Earnings 22.47b / Total Assets 34.43b) |
| C: 0.07 (EBIT TTM 2.81b / Avg Total Assets 37.87b) |
| D: 1.83 (Book Value of Equity 22.51b / Total Liabilities 12.29b) |
| Altman-Z'' Score: 6.77 = AAA |
Beneish M -2.54
| DSRI: 0.93 (Receivables 1.47b/1.65b, Revenue 34.13b/35.48b) |
| GMI: 1.28 (GM 17.62% / 22.59%) |
| AQI: 1.45 (AQ_t 0.48 / AQ_t-1 0.33) |
| SGI: 0.96 (Revenue 34.13b / 35.48b) |
| TATA: 0.05 (NI 2.08b - CFO 216.8m) / TA 34.43b) |
| Beneish M-Score: -2.54 (Cap -4..+1) = A |
What is the price of LEN shares?
As of February 09, 2026, the stock is trading at USD 114.02 with a total of 3,826,974 shares traded.
Over the past week, the price has changed by +4.74%, over one month by +7.68%, over three months by -4.82% and over the past year by -8.80%.
Over the past week, the price has changed by +4.74%, over one month by +7.68%, over three months by -4.82% and over the past year by -8.80%.
Is LEN a buy, sell or hold?
Lennar has received a consensus analysts rating of 3.48.
Therefor, it is recommend to hold LEN.
- StrongBuy: 4
- Buy: 2
- Hold: 15
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the LEN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 108.6 | -4.7% |
| Analysts Target Price | 108.6 | -4.7% |
| ValueRay Target Price | 119 | 4.3% |
LEN Fundamental Data Overview February 03, 2026
P/E Trailing = 13.9477
P/E Forward = 14.7929
P/S = 0.79
P/B = 1.251
P/EG = 2.3617
Revenue TTM = 34.13b USD
EBIT TTM = 2.81b USD
EBITDA TTM = 2.95b USD
Long Term Debt = 5.87b USD (from longTermDebt, last quarter)
Short Term Debt = 2.21b USD (from shortTermDebt, last quarter)
Debt = 6.32b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.51b USD (from netDebt column, last quarter)
Enterprise Value = 29.52b USD (27.01b + Debt 6.32b - CCE 3.80b)
Interest Coverage Ratio = 23.82 (Ebit TTM 2.81b / Interest Expense TTM 118.1m)
EV/FCF = 1000.0x (Enterprise Value 29.52b / FCF TTM 28.2m)
FCF Yield = 0.10% (FCF TTM 28.2m / Enterprise Value 29.52b)
FCF Margin = 0.08% (FCF TTM 28.2m / Revenue TTM 34.13b)
Net Margin = 6.09% (Net Income TTM 2.08b / Revenue TTM 34.13b)
Gross Margin = 17.62% ((Revenue TTM 34.13b - Cost of Revenue TTM 28.12b) / Revenue TTM)
Gross Margin QoQ = 16.29% (prev 17.67%)
Tobins Q-Ratio = 0.86 (Enterprise Value 29.52b / Total Assets 34.43b)
Interest Expense / Debt = 0.78% (Interest Expense 49.3m / Debt 6.32b)
Taxrate = 27.10% (185.1m / 683.0m)
NOPAT = 2.05b (EBIT 2.81b * (1 - 27.10%))
Current Ratio = 3.12 (Total Current Assets 17.14b / Total Current Liabilities 5.50b)
Debt / Equity = 0.29 (Debt 6.32b / totalStockholderEquity, last quarter 21.96b)
Debt / EBITDA = 0.85 (Net Debt 2.51b / EBITDA 2.95b)
Debt / FCF = 89.12 (Net Debt 2.51b / FCF TTM 28.2m)
Total Stockholder Equity = 22.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.49% (Net Income 2.08b / Total Assets 34.43b)
RoE = 9.25% (Net Income TTM 2.08b / Total Stockholder Equity 22.46b)
RoCE = 9.93% (EBIT 2.81b / Capital Employed (Equity 22.46b + L.T.Debt 5.87b))
RoIC = 7.53% (NOPAT 2.05b / Invested Capital 27.23b)
WACC = 6.83% (E(27.01b)/V(33.32b) * Re(8.30%) + D(6.32b)/V(33.32b) * Rd(0.78%) * (1-Tc(0.27)))
Discount Rate = 8.30% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.97%
[DCF Debug] Terminal Value 79.80% ; FCFF base≈909.7m ; Y1≈746.0m ; Y5≈531.3m
Fair Price DCF = 46.34 (EV 12.51b - Net Debt 2.51b = Equity 10.00b / Shares 215.8m; r=6.83% [WACC]; 5y FCF grow -21.63% → 2.90% )
EPS Correlation: -30.33 | EPS CAGR: 5.01% | SUE: -0.80 | # QB: 0
Revenue Correlation: 31.41 | Revenue CAGR: 11.60% | SUE: 0.52 | # QB: 0
EPS next Quarter (2026-05-31): EPS=1.45 | Chg30d=+0.003 | Revisions Net=-7 | Analysts=10
EPS current Year (2026-11-30): EPS=7.06 | Chg30d=-0.035 | Revisions Net=-8 | Growth EPS=-12.4% | Growth Revenue=-1.6%
EPS next Year (2027-11-30): EPS=8.82 | Chg30d=-1.058 | Revisions Net=-5 | Growth EPS=+24.8% | Growth Revenue=+5.8%
P/E Forward = 14.7929
P/S = 0.79
P/B = 1.251
P/EG = 2.3617
Revenue TTM = 34.13b USD
EBIT TTM = 2.81b USD
EBITDA TTM = 2.95b USD
Long Term Debt = 5.87b USD (from longTermDebt, last quarter)
Short Term Debt = 2.21b USD (from shortTermDebt, last quarter)
Debt = 6.32b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.51b USD (from netDebt column, last quarter)
Enterprise Value = 29.52b USD (27.01b + Debt 6.32b - CCE 3.80b)
Interest Coverage Ratio = 23.82 (Ebit TTM 2.81b / Interest Expense TTM 118.1m)
EV/FCF = 1000.0x (Enterprise Value 29.52b / FCF TTM 28.2m)
FCF Yield = 0.10% (FCF TTM 28.2m / Enterprise Value 29.52b)
FCF Margin = 0.08% (FCF TTM 28.2m / Revenue TTM 34.13b)
Net Margin = 6.09% (Net Income TTM 2.08b / Revenue TTM 34.13b)
Gross Margin = 17.62% ((Revenue TTM 34.13b - Cost of Revenue TTM 28.12b) / Revenue TTM)
Gross Margin QoQ = 16.29% (prev 17.67%)
Tobins Q-Ratio = 0.86 (Enterprise Value 29.52b / Total Assets 34.43b)
Interest Expense / Debt = 0.78% (Interest Expense 49.3m / Debt 6.32b)
Taxrate = 27.10% (185.1m / 683.0m)
NOPAT = 2.05b (EBIT 2.81b * (1 - 27.10%))
Current Ratio = 3.12 (Total Current Assets 17.14b / Total Current Liabilities 5.50b)
Debt / Equity = 0.29 (Debt 6.32b / totalStockholderEquity, last quarter 21.96b)
Debt / EBITDA = 0.85 (Net Debt 2.51b / EBITDA 2.95b)
Debt / FCF = 89.12 (Net Debt 2.51b / FCF TTM 28.2m)
Total Stockholder Equity = 22.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.49% (Net Income 2.08b / Total Assets 34.43b)
RoE = 9.25% (Net Income TTM 2.08b / Total Stockholder Equity 22.46b)
RoCE = 9.93% (EBIT 2.81b / Capital Employed (Equity 22.46b + L.T.Debt 5.87b))
RoIC = 7.53% (NOPAT 2.05b / Invested Capital 27.23b)
WACC = 6.83% (E(27.01b)/V(33.32b) * Re(8.30%) + D(6.32b)/V(33.32b) * Rd(0.78%) * (1-Tc(0.27)))
Discount Rate = 8.30% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.97%
[DCF Debug] Terminal Value 79.80% ; FCFF base≈909.7m ; Y1≈746.0m ; Y5≈531.3m
Fair Price DCF = 46.34 (EV 12.51b - Net Debt 2.51b = Equity 10.00b / Shares 215.8m; r=6.83% [WACC]; 5y FCF grow -21.63% → 2.90% )
EPS Correlation: -30.33 | EPS CAGR: 5.01% | SUE: -0.80 | # QB: 0
Revenue Correlation: 31.41 | Revenue CAGR: 11.60% | SUE: 0.52 | # QB: 0
EPS next Quarter (2026-05-31): EPS=1.45 | Chg30d=+0.003 | Revisions Net=-7 | Analysts=10
EPS current Year (2026-11-30): EPS=7.06 | Chg30d=-0.035 | Revisions Net=-8 | Growth EPS=-12.4% | Growth Revenue=-1.6%
EPS next Year (2027-11-30): EPS=8.82 | Chg30d=-1.058 | Revisions Net=-5 | Growth EPS=+24.8% | Growth Revenue=+5.8%